NCT01195974 - A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 14, 2010

Primary Completion Date

February 9, 2011

Study Completion Date

February 9, 2011

Conditions

Infection, Human Immunodeficiency VirusHIV Infections

Interventions

DRUG

YASMIN

YASMIN for 21 days

DRUG

GSK2248761

200 mg GSK2248761 taken on Days 1 - 10 or Days 12 - 21

OTHER

Placebo

Placebo taken on Days 1 - 10 or Days 12 - 21

Trial Locations (1)

GSK Investigational Site, Fargo